RecruitingNCT04308564
Laboratory and Clinical Data in Antiphospholipid Patients
Constitution d'Une Collection d'Echantillons Biologiques Associee a Une Base de Donnees de Patients Possedant Des Anticorps Antiphospholipides
Sponsor
Central Hospital, Nancy, France
Enrollment
60 participants
Start Date
Apr 12, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
To constitute a registry of antiphospholipid antibodies positive-patients
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- age between 18 and 60 years;
- persistent (at least 12 weeks apart) aPL-positivity within 12 months prior to screening
Exclusion Criteria3
- no inform consent
- impossible follow up
- pregnancy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTBlood test
Blood test for the identification of biomarkers
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04308564
Related Trials
Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome
NCT004827941 location
International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants
NCT042624921 location
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
NCT0019806810 locations
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
NCT070879122 locations
An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
NCT072367621 location